Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile
Journal for ImmunoTherapy of Cancer

@jitcancer

The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD

ID: 1150769339466952705

linkhttps://jitc.bmj.com/ calendar_today15-07-2019 14:09:25

6,6K Tweet

8,8K Takipçi

1,1K Takip Edilen

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

New #JITC article: Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study bit.ly/44VkjqA Tougeron David

New #JITC article: Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study bit.ly/44VkjqA <a href="/david_tougeron/">Tougeron David</a>